The global Extracorporeal Membrane Oxygenation Market was valued at US$ 294.2 million in 2021 and it is anticipated to grow up to US$ 411.3 million by 2031, at a CAGR of 7.4% during the forecast period.
Extracorporeal life support is another term for extracorporeal membrane oxygenation. It is a life-sustaining system that helps patients with severe respiratory failure by providing respiratory and cardiac support. Lung and heart diseases affect a large number of people in densely populated countries like China and India. This is expected to provide numerous opportunities for industry growth in these countries. According to the most recent data published by the World Health Organization in 2020, lung disease accounts for approximately 10% of all deaths in India. As a result of an increasing number of patients suffering from pulmonary disorders, advanced ECMO devices will become more widely used.
View The Full Report Here- https://www.globalinsightservices.com/reports/extracorporeal-membrane-oxygenation-ecmo-market/
Market Drivers and Trends
The rising awareness of the ECMO devices. Increasing patient awareness of the importance of cardiopulmonary assistance for severe cardiac and respiratory conditions will hasten ECMO therapy adoption. The introduction of patient education programs about the ECMO device and its use in emerging economies has resulted in an increase in demand. For example, the Latina Preventive Heart Disease program was launched in Latin America with the goal of raising awareness about advanced therapies and instruments for CVD diseases. Such initiatives aided the growth of the ECMO industry in this region.
Furthermore, Increase of survival rates by using ECMO. ECMO patient survival rates vary depending on the underlying condition and patient’s age. VV-ECMO is indicated for patients with potentially reversible respiratory failure. Patients with respiratory failure who receive VV-ECMO have a higher chance of survival. Because of their ability to support failing cardiovascular systems with oxygenation functions, ECMO machines are also used in cardiac applications. The above aforementioned factors can increase the market growth.
Unlock Growth Potential in Your Industry – Get Your Sample Report Now– https://www.globalinsightservices.com/request-sample/GIS24315
Market Restraints and Challenges
High cost of ECMO products, ECMO is a costly therapy. Besides from the costs of the systems, other expenses include such as cost of hospitalization and cost of additional disposable accessories. Furthermore, an entire team of medical professionals is required to care for the patient undergoing an ECMO procedure, which increases the cost of the treatment, though the cost varies depending on the duration of its use. The average hospital stay for a patient receiving ECMO support is typically 1-2 weeks. This raises the total cost of the procedure, which most patients cannot afford. Finally, these challenges can restrain the market growth.
Global Extracorporeal Membrane Oxygenation Market Segmental Overview
By Component
- Pumps
- Oxygenator
- Controllers
- Cannula
- Accessories
By Modality
- Veno-Arterial
- Veno-Venous
- Arterio-Venous
By Patient Type
- Neonates
- Pediatric
- Adult
By Application
- Respiratory
- Cardiac
- ECPR
Unlock Insights: Request Your Customizable Report Today – https://www.globalinsightservices.com/request-customization/GIS24315
Global Extracorporeal Membrane Oxygenation Market by Component
Based on component, it is segmented into pumps, oxygenator, controllers, cannula, and accessories. The oxygenator segment is expected to be the largest segment in the Extracorporeal Membrane Oxygenation Market in 2021. Furthermore, the high cost and rapid exchange rate for a different system are responsible for oxygenators’ large market size. Mechanical failure, pump head thrombosis, and acute oxygenator thrombosis are the main causes of oxygenator exchange rate. Pumps have a significant market share due to their high cost and usage. The segment’s growth can be attributed primarily to the high use of pumps in ECMO procedures and the availability of various types of pumps such as roller, impeller, and centrifugal.
Global Extracorporeal Membrane Oxygenation Market by Modality
Based on modality, the market is bifurcated into veno-arterial, veno-venous, and arterio-venous. The veno-arterial segment is expected to be the largest segment in the Extracorporeal Membrane Oxygenation Market in 2021. The segment’s largest size is primarily due to its widespread use in treating cardiac arrest patients, assisting with algorithm life support strategies to restore blood circulation. The veno-venous segment accounted for a significant share in 2021 and is expected to grow at a profitable rate. The rising prevalence of chronic obstructive pulmonary disease is one of the primary drivers of the ECMO machine market. According to the WHO, there were 251 million cases of COPD worldwide in 2016, with this figure expected to rise further in the upcoming years.
Global Extracorporeal Membrane Oxygenation Market by Patient Type
Based on patient type, the Extracorporeal Membrane Oxygenation Market is segmented into neonates, pediatric, and adult. The adult segment is expected to be the largest segment in the Extracorporeal Membrane Oxygenation Market in 2021. Alcohol, tobacco, and smoking use, combined with a sedentary lifestyle, are contributing to an increase in the global burden of cardiac and respiratory diseases in adults. According to a report published by the Extracorporeal Life Support Organization, there were approximately 7,850 adults suffering from cardiac illnesses that required ECMO. The pediatric segment also held a sizable market share and is expected to expand at a rapid pace during the period. The growing number of children suffering from various pulmonary heart diseases is one of the segment’s primary drivers. According to the Extracorporeal Life Support Organization, approximately 8,102 children suffered from cardiac illness and required ECMO therapy in the next decades.
Global Extracorporeal Membrane Oxygenation Market by Application
Based on application, the Extracorporeal Membrane Oxygenation Market is segmented into respiratory, cardiac, and ECPR. The respiratory is expected to maintain its dominance in the market throughout the period. The rising prevalence of respiratory disorders, as well as increased awareness of ECMO procedures, are key to the segmental growth. According to ELSO statistics, over 2,600 patients in the United States with respiratory illnesses received ECMO therapy in 2015. Due to the increasing incidence of cardiac surgery and rising awareness about ECMO machines in cardiac surgery, the cardiac surgery segment accounted for a significant market share in 2021. According to the American Heart Association, cardiovascular disease was responsible for roughly one out of every three deaths in the United States in 2016.
Geographical Analysis of Global Extracorporeal Membrane Oxygenation Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America held the greatest share of the global medical glove market (39.7%), because of the new products and number of companies in the market. The region’s growth is cause of the government support for quality healthcare, high purchasing power parity, and the increasing prevalence of diseases in the United States and Canada. The presence of advanced healthcare facilities and favorable reimbursement policies has resulted in an increase in hospital admissions.
The Asia-Pacific extracorporeal membrane oxygenation market is expected to grow the fastest. The increase in healthcare expenditure by the government and private agencies to improve healthcare facilities is one of the key factors driving the region’s growth. Economic development in countries such as Japan, India, and China, as well as rising government initiatives related to healthcare infrastructure development and reimbursement policies, are expected to boost market growth.
Major Players in the Global Extracorporeal Membrane Oxygenation Market
The key players studied in the global Extracorporeal Membrane Oxygenation Market are Abiomed (US), Braile Biomedica (Brazil), Fresenius Medical care AG & Co. KGaA (Germany), Getinge Group (Sweden), LivaNova (UK), Medos Medizintechnik AG (Germany), Medtronic (Ireland), Microport Scientific Corporation (China), Nipro Medical Corporation (Japan), and Terumo Cardiovascular Systems Corporation (US) among others.
Buy Now- https://www.globalinsightservices.com/checkout/single_user/GIS24315
COVID-19 Impact
The COVID-19 pandemic harmed the economy in 2020 and posed numerous challenges to clinical healthcare providers and patients worldwide. COVID-19 has also had an impact on various stages of the value chain, owing to strict lockdowns imposed by most governments. The delivery of goods and services has also been slowed as a result of newer packaging protocols and country-imposed lockdown measures. All of these factors have a negative impact on the production and supply chain of digital X-ray systems.
COVID-19, on the other hand, has created new opportunities for ECMO machine manufacturers and healthcare providers. Chest imaging has been considered as an alternative approach for patients with suspected or probable COVID-19 in settings where laboratory testing (RT-PCR) is not available, or results are delayed or initially negative. Imaging, such as chest radiography, CT scans, and lung ultrasounds, has been considered to complement clinical evaluation and laboratory parameters in the management of COVID-19 patients. According to the WHO, chest radiography can aid in the evaluation of COVID-19 pneumonia and its complications.
Recent Developments
- In July 2021, The Xenios Console and patient kits for ECMO therapy developed by Xenios AG have been approved by China’s National Medical Products Administration.
- In January 2021, in collaboration with the Eldorado Institute and Embrapii, Braile Biomedica launched the SOLIS System, a national product against COVID-19. Extracorporeal membrane oxygenation (ECMO), a type of extracorporeal breathing, is used in the system. The product launch helped the company maintain its market position while also broadening its product portfolio.
- In October 2020, The Abiomed Breethe OXY-1 System, an (ECMO) cardiopulmonary bypass system, has received FDA approval for COVID-19 treatment. This has contributed to the company’s business growth.
- In February 2020, Fresenius Medical Care AG & Co. KGaA received US FDA approval for Novalung, a heart and lung support system designed to treat acute respiratory or cardiopulmonary failure.
Research Scope
- Scope – Highlights, Trends, Insights. Attractiveness, Forecast
- Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others
- Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
- Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
- Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
- Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Infographic excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.